Avience Biomedicals GMP IPO Date, Review, Price, Allotment Details
Avience Biomedicals IPO Summary
IPO Open Date: 18 Jun 2026
IPO Close Date: 22 Jun 2026
Price Band: ₹196 to ₹208 Per Share
Issue Size: Approx ₹30.24 Crores
Listing Exchange: NSE SME
Website: https://avienbio.com/
Avience Biomedicals IPO Overview
Avience Biomedicals IPO is a book build issue of ₹30.24 crores. The issue is entirely a fresh issue of 0.15 crore shares of ₹30.24 crore.
Avience Biomedicals IPO opens for subscription on Jun 18, 2026 and closes on Jun 22, 2026. The allotment for the Avience Biomedicals IPO is expected to be finalized on Jun 23, 2026. Avience Biomedicals IPO will list on the NSE SME with a tentative listing date fixed as Jun 25, 2026.
Avience Biomedicals IPO is set issue price band at ₹196 to ₹208 per share. The lot size for an application is 600 shares. The minimum amount of investment required by an individual investor (retail) is ₹2,49,600 (1,200 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (1,800 shares), amounting to ₹3,74,400.
Avience Biomedicals IPO Details
| Company Name | Avience Biomedicals Ltd. |
| IPO Open Date | 18 Jun 2026 |
| IPO Close Date | 22 Jun 2026 |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹196 to ₹208 Per Share |
| Issue Size | Approx ₹30.24 Crores |
| Fresh Issue | Approx ₹30.24 Crores |
| Offer for Sale | - |
| Issue Type | Bookbuilding Issue |
| Listing On | NSE SME |
RHP
Avience Biomedicals IPO Market Lot
The Avience Biomedicals IPO minimum market lot is 1,200 shares with ₹2,49,600 application amount.
| Category | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 1,200 | ₹2,49,600 |
| Retail Maximum | 2 | 1,200 | ₹2,49,600 |
| S-HNI Minimum | 3 | 1,800 | ₹3,74,400 |
| S-HNI Maximum | 8 | 4,800 | ₹9,98,400 |
| B-HNI Minimum | 9 | 5,400 | ₹11,23,200 |
Avience Biomedicals IPO Reservation
| Investor Category | Shares Offered | % of Issue |
|---|---|---|
| Anchor Investor | 4,09,800 Shares | 28.19% |
| QIB (Ex. Anchor) | 2,73,600 Shares | 18.82% |
| NII / HNI | 2,07,000 Shares | 14.24% |
| Retail | 4,81,200 Shares | 33.10% |
Avience Biomedicals IPO Dates & Allotment
The Avience Biomedicals IPO date is June 18 and the close date is June 22. The Avience Biomedicals IPO allotment will be finalized on June 23 and the IPO listing on June 25.
| IPO Opening Date | 18 Jun 2026 |
| IPO Closing Date | 22 Jun 2026 |
| Bidding Cutoff Time | 5 PM |
| Basis of Allotment | 23 Jun 2026 |
| Refunds Initiation | 24 Jun 2026 |
| Credit to Demat | 24 Jun 2026 |
| IPO Listing Date | 25 Jun 2026 |
Avience Biomedicals IPO Objects of the Issue & Utilization of Proceeds
| Description | Amount |
|---|---|
| Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh | ₹15.96 |
| Funding the working capital requirements of the Company | ₹8.25 |
| General Corporate Purpose | ₹- |
Avience Biomedicals Ltd. Financials
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2024 | ₹24.37 | ₹21.43 | ₹2.14 | ₹34.65 |
| 2025 | ₹45.97 | ₹36.17 | ₹7.23 | ₹56.52 |
| Jan 2026 | ₹41.94 | ₹34.06 | ₹5.74 | ₹66.07 |
Avience Biomedicals IPO Valuation
Check Avience Biomedicals IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Parameter | Value |
|---|---|
| Earnings Per Share (EPS) | ₹19.06 (Basic) |
| P/E Ratio | N/A |
| Return on Equity (ROE) | -% |
| Return on Capital Employed (ROCE) | 24.88% |
| Return on Net Worth (RoNW) | 49.89% |
| Net Asset Value (NAV) | ₹56.50 |
| EBITDA Margin | 25.22% |
| PAT Margin | 15.86% |
| Debt to Equity Ratio | 0.97 |
Avience Biomedicals IPO Promoters & Holding Pattern
The promoters of the company are Mr. Dharam Deo Choudhary, Mr. Ram Nagina Choudhary, Mr. Janardan Pal and Ms. Deepa Choudhary.
| Particulars | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 40,31,256 | 87.89% |
| Promoter Holding Post Issue | 54,85,056 | 64.59% |
Avience Biomedicals IPO Lead Managers (Merchant Bankers)
- Fintellectual Corporate Advisors Pvt. Ltd.
About Avience Biomedicals Ltd.
Avience Biomedicals is a leading healthcare innovation firm dedicated to the research, development, and manufacturing of high-quality pharmaceutical and biomedical products. The company focuses on delivering advanced therapeutic solutions that address critical healthcare challenges across global markets. Committed to excellence, Avience Biomedicals leverages cutting-edge technology and rigorous quality standards to improve patient outcomes and drive medical progress.
Avience Biomedicals Ltd. Address
Janakpuri A-3, Delhi, New Delhi, 110058Phone: 1800-12-04-636
Email: [email protected]
Avience Biomedicals IPO Registrar
Skyline Financial Services Pvt. Ltd.
Phone: 022-28511022
Email: [email protected]
Website: https://www.skylinerta.com/ipo.php